openPR Logo
Press release

CME Accredited World’s leading Heart Congress

05-04-2018 10:24 AM CET | Health & Medicine

Press release from: Pulsus Group LTD

Pulsus Conference, Host of CME Accredited World’s leading Heart Congress, 2nd Global Heart Congress, the conference that discusses the New Paradigm Approach for Promoting Health and Intervention Strategies in Cardiology, Cardiovascular and Healthcare Industries. CME accredited Heart Congress 2018 will provide interactive sessions regarding the Recent and Innovative aspect followed in the field of cardiology and Cardiac healthcare industries. We will be providing delegates, speakers and students with CME accreditation. It also provides an opportunity to showcase your innovation in front of the world for a global recognition. The event is held at Hyatt Regency Osaka, Osaka, from 20-21 August 2018.
The conference will feature Keynote presentations by top Cardiologists, Cardiac Surgeons, Physicians & Cardiac Healthcare Industry professionals as well as renowned experts in regulatory field from all around the globe. Our Conference Organizing Committee Members are: Richard M. Fleming, Father of Modern Nuclear Cardiology & Nuclear Medicine, CEO of Omnific Imaging, USA; Sergey Suchkov, Director, Center for Personalized Medicine, Sechenov University, Russia; Pietro Maria G. Agricola, Chief - Cardiac Catheterization and Electrophysiology Laboratory , Mayor Hospital, Italy; Larry J. Díaz-Sandoval, Director, Cardiovascular Research, Metro Health-University of Michigan Health Hospital, USA, Kailash Prasad, Professor Emeritus, University of Saskatchewan, Canada. These are all among other exciting and high profile individuals who have shared knowledge of their experience at the Heart Congress 2018.
In addition, attendees will enjoy special events and lecturers featuring specialists and top scholars. It is a perfect platform for Cardiology educators, practitioners and researchers to exchange & share their experiences, research findings about all aspects of Cardiology and its related sub-branches.
Heart Congress 2018 will bring together the International blend of people from all over the globe in the field of Cardiology & medical devices companies, business entrepreneurs, Cardiology consultants, leading universities and research institutions making it the largest endeavour from Pulsus Conference. All the papers presented at this conference will be published in special issue of Journal of Current Research: Cardiology (Open Access).
Sessions to be discussed:
• Cardiology
• Rheumatic Heart Disease
• Cardiovascular Diseases
• Rare Heart Disease
• Cardiomyopathies and Heart Failure
• Heart Surgery
• Pharmacology of Heart
• Cardiac Nursing
• Cardiac Toxicity & Many more….

If you would like to know more information about this conference, To book a slot, Sponsorship and Exhibit sales information, Please contact
Name: Aravind A
Designation : Program Director | Heart Congress 2018
Tel: +1-408-429-2646
Email: or
Visit Website:

Pulsus Group is an internationally renowned medical peer-review publisher and conferences organizer established in the year 1984 publishes and hosts the work of researchers in a manner that exemplifies the highest standards in research integrity.

40 Bloomsbury Way,, Lower Ground Floor,

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CME Accredited World’s leading Heart Congress here

News-ID: 1039025 • Views: 360

More Releases from Pulsus Group LTD

World Congress on Probiotics, Prebiotics and Nutrition
Pulsus Group, host World Congress on Probiotics, Prebiotics and Nutrition, the Conference that discusses the Advanced trends for the future of various Nutritional treatments. Probiotics 2019 slated during January 28-29, 2019 at Dubai, UAE will schedule and coordinate all meetings with our Editorial Board Members and other experts in the Nutritional field across the world. The Probiotics conference scientific program paves a way to gather latest information through the research
Otorhinolaryngology, a product of the early century
Otorhinolaryngology, a product of the early century, developed from the blending of two different speciality departments of otology and laryngology. The twentieth century opened with brave tries to function skilful surgery underneath stipulations of primitive anaesthesia and no antibiotics. The stimulus of two world wars led to good sized advances in science and increased opportunities to explore new and resurrect ancient surgical procedures. The discovery of antibiotics noticed a cease

More Releases for Heart

Heart Congress 2019
Coalesce Research Group proudly announces the “International Conference on Heart & Clinical Cardiology Research” at Osaka, Japan during November 14-15, 2019. This Conference will be perfect platform for scientists, professors, healthcare professionals and cardiologists. Heart Congress 2019 is designed to provide diverse and recent research education on cardiovascular disease that keeps medical professionals along with issues heartrending on diagnosis, treatment of Cardiac disorders and prevention. In recent years, cardiac and
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after
Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF).
Prosthetic Heart Valve Market
Prosthetic (artificial) heart valve refers to a device implanted in the heart of a patient suffering from valvular heart disease. A cardiac surgery is performed to replace the abnormal heart valve with a prosthetic heart valve. Replacement of a diseased valve with a prosthetic heart valve results in reduction in morbidity and mortality associated with the cardiac valve disorder. When the treatment of heart valve disease reaches a stage where
Global Heart Implants Market
The Heart Implants Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. In a growing cardiac implants market where profits and growth prospects run together, many companies are vying to plunge into this untapped market. Heart implants are end-stage operations, where a failing